Navigating pharma strategy and portfolio prioritization: A Q&A
With capital markets in flux, regulatory headwinds, and scientific risks, boards and executives must navigate pharma strategy and portfolio prioritization.
With capital markets in flux, regulatory headwinds, and scientific risks, boards and executives must navigate pharma strategy and portfolio prioritization.
Learn how Vibe Bio is tackling the problem of funding & guiding high potential drug programs.
This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands.